印米他辛与纳米结构脂质载体的组合,以有效的抗癌疗法
Vaikunthavasan Thiruchenthooran1, Marta Espina2,3, Marta Świtalska4
1Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, Wrocław, Poland.
International journal of nanomedicine
|July 17, 2024
概括
这项研究开发了带有印美他素的纳米结构脂质载体 (IND-NLC),以提高抗癌效果. 与自由印米他辛相比,IND-NLC对癌细胞表现出优异的抗增殖活性.
科学领域:
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
- 在瘤学瘤学.
背景情况:
- 非类固醇抗炎药物 (NSAIDs),包括印米他辛,已知具有抗癌性质,但具有胃肠道副作用.
- 开发新的药物输送系统可以减轻副作用并改善治疗结果.
研究的目的:
- 为改善抗癌疗法,创建和描述带有印梅他辛的纳米结构脂质载体 (IND-NLC).
- 为了评估IND-NLC在体外对癌症细胞系的抗增殖活性.
主要方法:
- 在IND-NLC的制造中,采用高温高压均质化.
- 评估了物理化学性质,稳定性和体外抗癌疗效.
主要成果:
- IND-NLC具有最佳的粒子大小 (168.1 nm),负面电荷 (-30.1 mV),低的PDI (0.139),以及高的封装效率 (>99%).
- 超过60天,IND-NLC保持稳定,并有效抑制MDA-MB-468乳腺癌细胞生长 (15.7μM).
结论:
- 成功开发了IND-NLC用于向的印梅他辛输送,证实了增强的体外抗瘤疗效.
- 封装在NLC中的印梅他显示出显著的抗癌潜力,为癌症治疗提供了一个有希望的替代方案.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
8.9K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K